Skip to main content
. 2023 Aug 4;12(8):1285. doi: 10.3390/antibiotics12081285

Figure 8.

Figure 8

Antibiogram and the sequence-types distribution in carbapenem-resistant Klebsiella pneumoniae from the year 2022. SPZ cefoperazone–sulbactam, MEM meropenem, GEN gentamicin, TOB tobramycin, AMI amikacin, CIP ciprofloxacin, TET tetracycline, TGC tigecycline, COT co-trimoxazole (trimethoprim–sulfamethoxazole), COL colistin, FDC cefiderocol, CAZ/AVI ceftazidime–avibactam, IMP/REL imipenem–relebactam, MEM/VAB meropenem–vaborbaktam, KPC Klebsiella pneumoniae carbapenemase, NDM—New Delhi metallo-beta-lactamase. All isolates were resistant to ampicillin (intrinsic resistance); ampicillin–sulbactam, piperacillin–tazobactam, cefuroxime, cefotaxime, ceftazidime, cefepime, and ertapenem.